EIDD 2801 orally, cure and prevent ???

  1. 13,412 Posts.
    lightbulb Created with Sketch. 34
    Clinical studies evaluating an antiviral drug that is in development against SARS-CoV-2 are expected to begin later this spring (USA).
    Compared with other potential COVID-19 treatments that must be administered intravenously, EIDD-2801 can be delivered orally.
    results showed that, when used prophylactically, or administered early following infection, EIDD-2801 can prevent severe lung injury in infected animals....

    Scientists working to develop the drug, which is called EIDD-2801, suggest that if trials are successful, the drug could not only be used to limit the spread of SARS-CoV-2, but could also control future outbreaks of other emerging coronaviruses.

    .. all human coronaviruses are thought to have emerged as zoonoses, the researchers pointed out. Zoonotic diseases are those that have made the species jump from animals into humans. “More alarmingly,” they further noted, there are many SARS-like and MERS-like coronaviruses circulating in bat reservoir species that can use human receptors and replicate efficiently in primary human lung cells, without adaptation.
    https://www.genengnews.com/news/clinical-trial-evaluating-oral-drug-against-coronavirus-expected-to-start-later-this-spring/

 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.